Geschickten Expands Product Portfolio in Bid to Increase its Footprint | GenomeWeb

By Uduak Grace Thomas

Bangalore, India-based bioinformatics firm Geschickten is making some changes to its business model and product lines in a bid to increase its customer base and expand its footprint.

The company plans to release three new software tools in the fall: miGenX, a web-based statistical package for microarray data analysis; Discoverer, a federated web-based human gene mutational database; and Gtrac, a web-based system for tracking next-generation sequencing projects.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."